Oncogenic Ras suppresses Cdk1 in a complex manner during the incubation of activated Xenopus egg extracts

Tun-Lan Huang1, Jerry P Pian, Bin-Tao Pan

  • 1Graduate Center for Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA.

Insights

Oncogenic Ras suppresses Cdk1 activation by maintaining inhibitory phosphorylation and causing continuous cyclin B2 accumulation in Xenopus egg extracts, revealing a complex regulatory mechanism.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinase 1 (Cdk1) activation drives M-phase entry in the cell cycle.
  • Cdk1 activation depends on cyclin B synthesis, binding, and removal of inhibitory Tyr15 phosphorylation.
  • Oncogenic Ras is known to suppress Cdk1 activation, but the mechanism remains unclear.

Purpose of the Study:

  • To elucidate the mechanism by which oncogenic Ras suppresses Cdk1 activation.
  • To investigate the effects of oncogenic Ras on cyclin B2 levels and Tyr15-Cdk1 phosphorylation.

Main Methods:

  • Utilized Xenopus egg extracts for cell-free experiments.
  • Employed histone H1 kinase assays to measure Cdk1 activity.
  • Performed Western blot analysis to quantify cyclin B2 and phosphorylated Tyr15-Cdk1 levels.

Main Results:

  • Oncogenic Ras induces persistent inhibitory phosphorylation of Tyr15-Cdk1.
  • Oncogenic Ras leads to continuous accumulation of cyclin B2, unlike the transient accumulation in controls.
  • Cyclin B2 stabilization, mediated by the Raf-Mek-Erk-p90(rsk) pathway, underlies its continuous accumulation.

Conclusions:

  • Oncogenic Ras suppresses Cdk1 through a dual mechanism: persistent inhibitory phosphorylation and continuous cyclin B2 accumulation.
  • The Raf-Mek-Erk-p90(rsk) pathway is crucial for oncogenic Ras-induced cyclin B2 stabilization.
  • This study reveals a complex interplay between oncogenic signaling and cell cycle regulation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...